Europe Coagulation Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Coagulation Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Coagulation Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Coagulation Market Regional Analysis

6.2 Europe Coagulation Market Revenue 2020-2030 (US$ Million)

6.3 Europe Coagulation Market Forecast Analysis

7. Europe Coagulation Market Analysis – by Disease Indications

7.1 Vitamin K Deficiency

7.1.1 Overview
7.1.2 Vitamin K Deficiency: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Liver Disease

7.2.1 Overview
7.2.2 Liver Disease: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Disseminated Intravascular Coagulation & Pulmonary Embolism

7.3.1 Overview
7.3.2 Disseminated Intravascular Coagulation & Pulmonary Embolism: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Development of Circulating Anticoagulants

7.4.1 Overview
7.4.2 Development of Circulating Anticoagulants: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.5 Hemophilia

7.5.1 Overview
7.5.2 Hemophilia: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.6 Von Willebrand\'s Disease

7.6.1 Overview
7.6.2 Von Willebrand\'s Disease: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Coagulation Market Analysis – by Type

8.1 Clinical Laboratory Analyzers

8.1.1 Overview
8.1.2 Clinical Laboratory Analyzers: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Point-of-Care Testing Analyzers

8.2.1 Overview
8.2.2 Point-of-Care Testing Analyzers: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Coagulation Market Analysis – by Offering

9.1 Prothrombin Time Testing

9.1.1 Overview
9.1.2 Prothrombin Time Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Fibrinogen Testing

9.2.1 Overview
9.2.2 Fibrinogen Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Activated Clotting Time Testing

9.3.1 Overview
9.3.2 Activated Clotting Time Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Activated Partial Thromboplastin Time Testing

9.4.1 Overview
9.4.2 Activated Partial Thromboplastin Time Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.5 D-Dimmer Testing

9.5.1 Overview
9.5.2 D-Dimmer Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.6 Platelets Function Testing

9.6.1 Overview
9.6.2 Platelets Function Testing: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Coagulation Market Analysis – by Treatment

10.1 Anti-Fibrinolytic Drugs

10.1.1 Overview
10.1.2 Anti-Fibrinolytic Drugs: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Birth Control Pills

10.2.1 Overview
10.2.2 Birth Control Pills: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Desmopressin & Immunosuppressive Medicines

10.3.1 Overview
10.3.2 Desmopressin & Immunosuppressive Medicines: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.4 Vitamin K Supplements

10.4.1 Overview
10.4.2 Vitamin K Supplements: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.5 Blood Thinners

10.5.1 Overview
10.5.2 Blood Thinners: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.6 Thrombin Inhibitors or Thrombolytics

10.6.1 Overview
10.6.2 Thrombin Inhibitors or Thrombolytics: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.7 Replacement Therapy

10.7.1 Overview
10.7.2 Replacement Therapy: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.8 Catheter-Assisted Thrombus Removal

10.8.1 Overview
10.8.2 Catheter-Assisted Thrombus Removal: Europe Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Coagulation Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Coagulation Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Coagulation Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.1.2 UK: Europe Coagulation Market Breakdown, by Type
11.2.1.1.3 UK: Europe Coagulation Market Breakdown, by Offering
11.2.1.1.4 UK: Europe Coagulation Market Breakdown, by Treatment

11.2.1.2 Germany: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.2.2 Germany: Europe Coagulation Market Breakdown, by Type
11.2.1.2.3 Germany: Europe Coagulation Market Breakdown, by Offering
11.2.1.2.4 Germany: Europe Coagulation Market Breakdown, by Treatment

11.2.1.3 France: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.3.2 France: Europe Coagulation Market Breakdown, by Type
11.2.1.3.3 France: Europe Coagulation Market Breakdown, by Offering
11.2.1.3.4 France: Europe Coagulation Market Breakdown, by Treatment

11.2.1.4 Russia: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.4.2 Russia: Europe Coagulation Market Breakdown, by Type
11.2.1.4.3 Russia: Europe Coagulation Market Breakdown, by Offering
11.2.1.4.4 Russia: Europe Coagulation Market Breakdown, by Treatment

11.2.1.5 Italy: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.5.2 Italy: Europe Coagulation Market Breakdown, by Type
11.2.1.5.3 Italy: Europe Coagulation Market Breakdown, by Offering
11.2.1.5.4 Italy: Europe Coagulation Market Breakdown, by Treatment

11.2.1.6 Rest of Europe: Europe Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Coagulation Market Breakdown, by Disease Indications
11.2.1.6.2 Rest of Europe: Europe Coagulation Market Breakdown, by Type
11.2.1.6.3 Rest of Europe: Europe Coagulation Market Breakdown, by Offering
11.2.1.6.4 Rest of Europe: Europe Coagulation Market Breakdown, by Treatment

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Genrui Biotech Co., Ltd

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Horiba Ltd.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Nordic Biomarker AB

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Siemens Healthineers AG

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sysmex Corp

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Transasia Bio-Medicals Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Coagulation Market